Ingemar Turesson
111 – 120 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis.
(
- Contribution to journal › Article
-
Mark
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
(
- Contribution to journal › Article
- 2002
-
Mark
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase - a report from the Swedish CML Group
(
- Contribution to journal › Article
-
Mark
Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation
(
- Contribution to journal › Article
-
Mark
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
(
- Contribution to journal › Article
-
Mark
Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy.
(
- Contribution to journal › Article
-
Mark
Sensitizing and protective substances in radiation therapy and predictive assays
(
- Contribution to journal › Article
- 1993
-
Mark
Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Hepatit C. Förekomst och relevans hos multitransfunderade patienter med hematologisk sjukdom
(
- Contribution to journal › Article
- 1982
-
Mark
Is occult atrial disorder a frequent cause of non-hemorrhagic stroke? Long-term ECG in 86 patients
(
- Contribution to journal › Article